| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/18/2002 | US6406877 Purified and isolated tumor necrosis factor-alpha converting enzyme, the nucleic acids that encode it, and processes for its recombination |
| 06/18/2002 | US6406870 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes |
| 06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
| 06/18/2002 | US6406863 High throughput generation and screening of fully human antibody repertoire in yeast |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406855 Detection of cytokines and nucleic acid subsequences of polynucleotides and injections |
| 06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
| 06/18/2002 | US6406701 Reducing the susceptibility of t lymphocytes to hiv infection |
| 06/18/2002 | US6406697 Amino acid sequence of ligand binding partner protein fused to c-terminus to n-terminus of immunoglobulin and cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods. |
| 06/18/2002 | US6406696 Activation of t cells, immunopotentiation and immunology, administering anti-cd3 monoclonal antibodies |
| 06/18/2002 | US6406695 Treatment of hepatitis C by administration of anti-IL-2 receptor monoclonal antibody |
| 06/18/2002 | US6406694 Anti-CCR2 antibodies |
| 06/18/2002 | US6406693 Killing tumor vascular endothelial cells by treatment with antibodies and binding with antigens |
| 06/18/2002 | CA2098819C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 06/18/2002 | CA2034611C Synthetic peptide compositions with immunoreactivities to antibodies to htlv |
| 06/18/2002 | CA2025566C Method for the determination of pathogenic listeria bacteria |
| 06/13/2002 | WO2002046769A2 A monoclonal antibody-based diagnostic assay for gamma fibrinogen |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | WO2002046466A2 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046455A2 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 06/13/2002 | WO2002046435A2 Engineered plasmids and their use for in situ production of genes |
| 06/13/2002 | WO2002046434A2 Plasmid vectors |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046422A1 Single-chain variable fragment antibodies specific for the synaptic variant of acetylcholinesterase (ache-s), and their use in the diagnosis of progressive neuromuscular disorders |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046417A2 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | WO2002046415A2 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 06/13/2002 | WO2002046414A2 Human g-protein coupled receptor expressed highly in kidney |
| 06/13/2002 | WO2002046411A2 Intestinal proteins |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/13/2002 | WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 06/13/2002 | WO2002046238A2 Rationally designed antibodies |
| 06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
| 06/13/2002 | WO2002046236A1 Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 06/13/2002 | WO2002046235A1 Human monoclonal antibody directed against the influenza virus or a fragment thereof |
| 06/13/2002 | WO2002046234A1 Cocaine haptens |
| 06/13/2002 | WO2002046233A1 Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof |
| 06/13/2002 | WO2002046232A2 Multimeric single-chain antibody with multiple antigen binding |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046227A2 Glp-1 fusion proteins |
| 06/13/2002 | WO2002046224A2 Compositions and methods relating to lung specific genes and proteins |
| 06/13/2002 | WO2002046222A2 Compositions and methods for diagnosing alzheimer's disease |
| 06/13/2002 | WO2002046219A2 Rho-gtpase activating proteins and methods related thereto |
| 06/13/2002 | WO2002046216A2 Human sprouty-4 polypeptide |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | WO2002045747A1 Immunotherapeutic combinations for the treatment of tumors |
| 06/13/2002 | WO2002045742A2 Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
| 06/13/2002 | WO2002045740A1 Compositions containing gangliosides for use in the treatment of skin disorders |
| 06/13/2002 | WO2002045653A2 Combination radiation therapy and chemotherapy in conjuction with administration of growth factor receptor antibody |
| 06/13/2002 | WO2002031464A3 Evaluating binding affinities by force stratification and force planning |
| 06/13/2002 | WO2002020554A3 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 06/13/2002 | WO2002020038A3 Method for down-regulating ige |
| 06/13/2002 | WO2002017857A3 Methods and compositions for inhibiting angiogenesis |
| 06/13/2002 | WO2002012339A3 Sequences for integrin alpha-8 |
| 06/13/2002 | WO2002000729A3 Generation of libraries of antibodies in yeast and uses thereof |
| 06/13/2002 | WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 06/13/2002 | WO2001096377A3 Vaccine for congenital tremors in pigs |
| 06/13/2002 | WO2001094415A3 Nuclear hormone receptor |
| 06/13/2002 | WO2001094362A3 Haplotypes of the acp2 gene |
| 06/13/2002 | WO2001092294A3 Therapeutic anti-melanoma compounds |
| 06/13/2002 | WO2001087981A3 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 06/13/2002 | WO2001083550A3 Gpr22 modulators as appetite-control agents |
| 06/13/2002 | WO2001046357A3 Detergent compositions comprising benefit agents |
| 06/13/2002 | WO2001044300A3 Brain specific binding members |
| 06/13/2002 | WO2001042461A3 Apoptin-associating protein |
| 06/13/2002 | WO2001029256A3 Cephalic pain susceptibility marker |
| 06/13/2002 | US20020073447 Acquired resistance genes and uses thereof |
| 06/13/2002 | US20020073446 Genetically modified plants having modulated brassinosteroid signaling |
| 06/13/2002 | US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders |
| 06/13/2002 | US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 06/13/2002 | US20020072592 Nucleotide sequences which code anticarcinogenic agent for use in the treatment mammary gland cancer |
| 06/13/2002 | US20020072588 Recombinant antibody fragments as autoantibody antagonists |
| 06/13/2002 | US20020072497 Novel DNA and recombinant production of novel polypeptides |
| 06/13/2002 | US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072491 Homology to members of the myosin light chain kinase subfamily |
| 06/13/2002 | US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides |
| 06/13/2002 | US20020072107 Human osteoclast derived cathepsin |
| 06/13/2002 | US20020072106 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | US20020072093 Novel leader peptides for enhancing secretion of recombinant protein from a host cell |
| 06/13/2002 | US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072090 Hr-1 receptor |
| 06/13/2002 | US20020072080 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 06/13/2002 | US20020072077 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy |
| 06/13/2002 | US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072066 Human osteoporosis gene |
| 06/13/2002 | US20020071847 Present on the surface of Borrelia burgdorferi cells that lack the outer membrane proteins OspA, OspB, OspC and OspD; sensitive to cleavage with proteinase K; having binding affinity for certain monoclonal antibodies |